MMC
NAMS icon

Mizuho Markets Cayman’s NewAmsterdam Pharma NAMS Stock Holding History

Mizuho Markets Cayman’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.1M Buy
150,539
+98,312
+188% +$3.24M 0.19% 47
2026
Q1 		$1.67M Buy
52,227
+4,348
+9% +$142K 0.09% 56
2025
Q4 		$1.68M Buy
+47,879
New +$1.74M 0.08% 65

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Mizuho Markets Cayman's NAMS Position: Q2 2026 in Review

Mizuho Markets Cayman increased its NewAmsterdam Pharma (NAMS) stake by 188% in Q2 2026, buying an estimated $3.24M and bringing the position to 150,539 shares worth $5.1M. The position accounts for 0.19% of the portfolio, ranked #47.

Mizuho Markets Cayman first reported a position in NAMS in Q4 2025 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Mizuho Markets Cayman held 150,539 shares of NewAmsterdam Pharma worth $5.1M as of Q2 2026.
  • Mizuho Markets Cayman bought 98,312 NewAmsterdam Pharma shares in Q2 2026, an estimated $3.24M.
  • NewAmsterdam Pharma made up 0.19% of Mizuho Markets Cayman's portfolio in Q2 2026, its #47 holding.
  • Mizuho Markets Cayman first reported a position in NewAmsterdam Pharma in Q4 2025 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Mizuho Markets Cayman's 13F filing for Q2 2026, filed 24 Jul 2026.